J. He

发表

Pharmacological differences between rat and human endothelin B receptors.

A. Doherty, B. Steinbaugh, W. L. Cody, 1995, Biochemical and biophysical research communications.

In vitro and in vivo studies with a series of hexapeptide endothelin antagonists.

A. Doherty, W. L. Cody, E. Reynolds, 1993, Journal of cardiovascular pharmacology.

Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.

A. Sefler, W. L. Cody, D. Leonard, 1995, Journal of medicinal chemistry.

Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.

A. Doherty, D. T. Dudley, W. L. Cody, 1993, Journal of medicinal chemistry.

Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications.

D. R. Holland, J. DiMaio, A. Doherty, 1998, Bioorganic & medicinal chemistry letters.

The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1.

A. Doherty, J. Rubin, P. Winocour, 1999, Bioorganic & medicinal chemistry letters.

The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.

Junxian He, T. Akao, J. He, 2001, Biological & pharmaceutical bulletin.

Design of a functional hexapeptide antagonist of endothelin.

A. Doherty, R. Panek, T. Major, 1992, Journal of medicinal chemistry.

In vitro assessment of oral delivery for hexapeptide endothelin antagonists.

A. Doherty, B. H. Stewart, E. Reyner, 1996, Life sciences.

Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.

A. Doherty, M. Reily, B. H. Stewart, 1997, Journal of medicinal chemistry.

Functional activity of new C-terminal cyclic-neurotensin fragment analogs

H. Akunne, A. Sefler, T. Pugsley, 1996, Neuropeptides.

Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.

T. Heffner, H. Akunne, A. Sefler, 2009, International journal of peptide and protein research.

Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.

M. Reily, H. Akunne, A. Sefler, 1995, Journal of Medicinal Chemistry.